1 Page 1 2 Page 2 3 Preview 4 Complete Page 1 of 4 (0%) Please note that completion of this evaluation form is required to receive credits. Please complete the evaluation by answering all questions.The purpose of this evaluation is to improve our courses. Your response is sincerely appreciated. Please choose your profession: * Pharmacist Technician Other Please choose your profession: Other Please enter your NABP e-Profile ID * This is required to receive your CEUs/Contact Hours. If you do not have an NABP e-Profile ID or are from outside of the United States, please enter N/A. Date of Birth * Month MonthJanFebMarAprMayJunJulAugSepOctNovDecMonth Day Day12345678910111213141516171819202122232425262728293031Day Year Year20232024202520262027 Each statement in this section of the program evaluation is based on a seven (7) point scale. There are 20 statements requiring your evaluation. Generally speaking, I feel ready and able to apply newly acquired knowledge and/or skills applicable to… * Strongly AgreeAgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeDisagreeStrongly Disagree Strongly AgreeAgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeDisagreeStrongly Disagree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Strongly Agree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Agree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Somewhat Agree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Neither Agree nor Disagree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Somewhat Disagree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Disagree The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding. - Strongly Disagree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Strongly Agree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Agree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Somewhat Agree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Neither Agree nor Disagree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Somewhat Disagree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Disagree Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023. - Strongly Disagree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Strongly Agree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Agree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Somewhat Agree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Neither Agree nor Disagree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Somewhat Disagree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Disagree Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023. - Strongly Disagree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Strongly Agree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Agree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Somewhat Agree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Neither Agree nor Disagree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Somewhat Disagree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Disagree The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding. - Strongly Disagree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Strongly Agree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Agree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Somewhat Agree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Neither Agree nor Disagree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Somewhat Disagree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Disagree Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023. - Strongly Disagree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Strongly Agree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Agree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Somewhat Agree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Neither Agree nor Disagree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Somewhat Disagree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Disagree Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023. - Strongly Disagree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Strongly Agree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Agree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Somewhat Agree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Neither Agree nor Disagree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Somewhat Disagree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Disagree Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023. - Strongly Disagree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Strongly Agree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Agree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Somewhat Agree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Neither Agree nor Disagree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Somewhat Disagree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Disagree Cleaning and disinfecting as outlined in USP <797> § 6, 2023. - Strongly Disagree Pharmaceutical calculations related to sterile dosage forms. Pharmaceutical calculations related to sterile dosage forms. - Strongly Agree Pharmaceutical calculations related to sterile dosage forms. - Agree Pharmaceutical calculations related to sterile dosage forms. - Somewhat Agree Pharmaceutical calculations related to sterile dosage forms. - Neither Agree nor Disagree Pharmaceutical calculations related to sterile dosage forms. - Somewhat Disagree Pharmaceutical calculations related to sterile dosage forms. - Disagree Pharmaceutical calculations related to sterile dosage forms. - Strongly Disagree Aseptic processing, and release inspection and testing. Aseptic processing, and release inspection and testing. - Strongly Agree Aseptic processing, and release inspection and testing. - Agree Aseptic processing, and release inspection and testing. - Somewhat Agree Aseptic processing, and release inspection and testing. - Neither Agree nor Disagree Aseptic processing, and release inspection and testing. - Somewhat Disagree Aseptic processing, and release inspection and testing. - Disagree Aseptic processing, and release inspection and testing. - Strongly Disagree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Strongly Agree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Agree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Somewhat Agree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Neither Agree nor Disagree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Somewhat Disagree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Disagree Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023. - Strongly Disagree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Strongly Agree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Agree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Somewhat Agree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Neither Agree nor Disagree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Somewhat Disagree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Disagree CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023. - Strongly Disagree The compounding and management of Allergenic Extracts. The compounding and management of Allergenic Extracts. - Strongly Agree The compounding and management of Allergenic Extracts. - Agree The compounding and management of Allergenic Extracts. - Somewhat Agree The compounding and management of Allergenic Extracts. - Neither Agree nor Disagree The compounding and management of Allergenic Extracts. - Somewhat Disagree The compounding and management of Allergenic Extracts. - Disagree The compounding and management of Allergenic Extracts. - Strongly Disagree Hazard communication program, and API risk management as identified in USP <800>, 2020. Hazard communication program, and API risk management as identified in USP <800>, 2020. - Strongly Agree Hazard communication program, and API risk management as identified in USP <800>, 2020. - Agree Hazard communication program, and API risk management as identified in USP <800>, 2020. - Somewhat Agree Hazard communication program, and API risk management as identified in USP <800>, 2020. - Neither Agree nor Disagree Hazard communication program, and API risk management as identified in USP <800>, 2020. - Somewhat Disagree Hazard communication program, and API risk management as identified in USP <800>, 2020. - Disagree Hazard communication program, and API risk management as identified in USP <800>, 2020. - Strongly Disagree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Strongly Agree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Agree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Somewhat Agree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Neither Agree nor Disagree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Somewhat Disagree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Disagree Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020. - Strongly Disagree Personal protective equipment and containment-engineering controls for hazardous drug compounding. Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Strongly Agree Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Agree Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Somewhat Agree Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Neither Agree nor Disagree Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Somewhat Disagree Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Disagree Personal protective equipment and containment-engineering controls for hazardous drug compounding. - Strongly Disagree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Strongly Agree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Agree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Somewhat Agree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Neither Agree nor Disagree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Somewhat Disagree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Disagree Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding. - Strongly Disagree Environmental wipe sampling for hazardous drug compounding. Environmental wipe sampling for hazardous drug compounding. - Strongly Agree Environmental wipe sampling for hazardous drug compounding. - Agree Environmental wipe sampling for hazardous drug compounding. - Somewhat Agree Environmental wipe sampling for hazardous drug compounding. - Neither Agree nor Disagree Environmental wipe sampling for hazardous drug compounding. - Somewhat Disagree Environmental wipe sampling for hazardous drug compounding. - Disagree Environmental wipe sampling for hazardous drug compounding. - Strongly Disagree Labeling, packaging, transport, and disposal of hazardous drugs. Labeling, packaging, transport, and disposal of hazardous drugs. - Strongly Agree Labeling, packaging, transport, and disposal of hazardous drugs. - Agree Labeling, packaging, transport, and disposal of hazardous drugs. - Somewhat Agree Labeling, packaging, transport, and disposal of hazardous drugs. - Neither Agree nor Disagree Labeling, packaging, transport, and disposal of hazardous drugs. - Somewhat Disagree Labeling, packaging, transport, and disposal of hazardous drugs. - Disagree Labeling, packaging, transport, and disposal of hazardous drugs. - Strongly Disagree Dispensing, compounding, and administering hazardous CSPs. Dispensing, compounding, and administering hazardous CSPs. - Strongly Agree Dispensing, compounding, and administering hazardous CSPs. - Agree Dispensing, compounding, and administering hazardous CSPs. - Somewhat Agree Dispensing, compounding, and administering hazardous CSPs. - Neither Agree nor Disagree Dispensing, compounding, and administering hazardous CSPs. - Somewhat Disagree Dispensing, compounding, and administering hazardous CSPs. - Disagree Dispensing, compounding, and administering hazardous CSPs. - Strongly Disagree Leave this field blank
